Abstract

Untreated twin-to-twin transfusion syndrome (TTTS) is associated with a high risk of perinatal mortality and morbidity. Laser surgery is recommended before 26weeks of gestation. However, the optimal management in case of late TTTS (occurring after 26weeks of gestation) is yet to be established. We conducted a systematic review and meta-analysis to evaluate the outcomes of monochorionic-diamniotic twin pregnancies complicated by late TTTS according to different management options (expectant, laser therapy, amnioreduction, or delivery). The primary outcome was mortality, including single and double intrauterine, neonatal, and perinatal death. Secondary outcomes were composite morbidity, neuromorbidity, respiratory distress syndrome, admission to neonatal intensive care unit, intact survival (ie, free from neurological complications), and preterm birth before <32weeks of gestation. Outcomes were reviewed according to the management and reported for the overall population of twins and disease status (ie, donor and recipient separately). Random-effect meta-analyses of proportions were used to analyze the data. Nine studies including 796 twin pregnancies affected by TTTS were included. No randomized controlled trials were available for inclusion. TTTS occurred at ≥26weeks of gestation in 8.7% (95% CI 6.9%-10.9%; 67/769) of cases reporting TTTS at all gestations. Intrauterine death occurred in 17.7% (95% CI 4.9%-36.2%) of pregnancies managed expectantly, 5.3% (95% CI 0.9%-12.9%) of pregnancies treated with laser, and 0% (95% CI 0%-9%) after amnioreduction. Neonatal death occurred in 42.5% (95% CI 17.5%-69.7%) of pregnancies managed expectantly, in 2.8% (95% CI 0.3%-7.7%) of cases treated with laser, and in 20.2% (95% CI 6%-40%) after amnioreduction. Only one study (10 cases) reported data on immediate delivery after diagnosis with no perinatal deaths. Perinatal death incidence was 55.7% (95% CI 31.4%-78.6%) in twin pregnancies managed expectantly, 5.6% (95% CI 0.5%-15.3%) in those treated with laser, and 20.2% (95% CI 6%-40%) in those after amnioreduction. Intact survival was reported in 44.4%, 96.4%, and 78% of fetuses managed expectantly, with laser or amnioreduction, respectively. Evidence regarding perinatal mortality and morbidity in twin pregnancies complicated by late TTTS according to the different managements was of very low quality. Therefore further high-quality research in this field is needed to elucidate the optimal management of these pregnancies.

Highlights

  • Untreated Twin-to-twin transfusion syndrome (TTTS) is associated with a high risk of perinatal mortality and morbidity

  • Material and methods: We conducted a systematic review and meta-analysis to evaluate the outcomes of monochorionic diamniotic twin pregnancies complicated by late TTTS according to different management options

  • When stratifying monochorionic diamniotic (MCDA) pregnancies according to Quintero staging, the overall survival is higher at earlier Quintero stages (I-II), but perinatal survival rates are reasonable even at stage III and IV when treated with laser therapy [8]

Read more

Summary

Introduction

Untreated Twin-to-twin transfusion syndrome (TTTS) is associated with a high risk of perinatal mortality and morbidity. Potential maternal risks, technical issues (such as a bigger uterine cavity, larger anastomoses, larger fetuses, etc) restrictions by regulatory agencies and the relative more benign course of TTTS after 26 weeks have been reported as reasons for offering less invasive therapeutic options such as serial amnioreductions and even iatrogenic preterm delivery when viability was reached [9,10]. Both options carry a significant risk of neonatal death and long-term neurological impairment in survivors; in particular, amnioreduction was associated with a 23% rate of neurological sequelae [11,12] while death and/or severe neurological injury among infants born between 26 and 28 weeks is reported to be around 37% [13].

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.